NM_002047.4(GARS1):c.929G>A (p.Arg310Gln) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Sep 28, 2019
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004023320.1

Allele description [Variation Report for NM_002047.4(GARS1):c.929G>A (p.Arg310Gln)]

NM_002047.4(GARS1):c.929G>A (p.Arg310Gln)

Gene:

GARS1:glycyl-tRNA synthetase 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p14.3

Genomic location:

Preferred name:

NM_002047.4(GARS1):c.929G>A (p.Arg310Gln)

HGVS:

NC_000007.14:g.30612143G>A
NG_007942.1:g.22579G>A
NM_001316772.1:c.767G>A
NM_002047.4:c.929G>AMANE SELECT
NP_001303701.1:p.Arg256Gln
NP_002038.2:p.Arg310Gln
LRG_243t1:c.929G>A
LRG_243:g.22579G>A
NC_000007.13:g.30651759G>A
NM_002047.2:c.929G>A
NM_002047.3:c.929G>A

Protein change:

R256Q

Links:

dbSNP: rs1135401748

NCBI 1000 Genomes Browser:

rs1135401748

Molecular consequence:

NM_001316772.1:c.767G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_002047.4:c.929G>A - missense variant - [Sequence Ontology: SO:0001583]

Functional consequence:

effect on protein activity [Variation Ontology: 0053]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002755179	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Sep 28, 2019)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002755179

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Sep 28, 2019)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV002755179.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.R310Q variant (also known as c.929G>A), located in coding exon 8 of the GARS gene, results from a G to A substitution at nucleotide position 929. The arginine at codon 310 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine